Albendazole 400 mg

DRUG4 trials

Sponsors

GlaxoSmithKline, Jennifer Keiser, Mundo Sano Foundation, Uwemedimo Friday Ekpo

Conditions

AscariasisHookworm InfectionIntestinal DiseasesLymphatic FilariasisOnchocerciasis (River Blindness)SchistosomiasisSoil Transmitted Helminth (STH) InfectionsSoil-Transmitted Helminthiasis

Phase 1

Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions

CompletedNCT06201559

GlaxoSmithKlineIntestinal Diseases

Start: 2023-08-21End: 2023-09-12Updated: 2025-01-27

Phase 2

Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

Not yet recruitingNCT07258173

Jennifer KeiserTrichuris Infection

Start: 2026-05-15End: 2026-09-15Target: 100Updated: 2026-05-08

Phase 3

Combination Therapies for Trichuris Trichiura Infection in Schoolchildren in Honduras

Not yet recruitingNCT07661316

Mundo Sano FoundationAscariasis, Hookworm Infection, Soil-Transmitted Helminthiasis +2

Start: 2026-11-01End: 2027-05-31Target: 368Updated: 2026-06-23

Unknown Phase

Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations

RecruitingNCT07707817

Uwemedimo Friday EkpoLymphatic Filariasis, Onchocerciasis (River Blindness), Schistosomiasis +1

Start: 2026-07-01End: 2027-11-30Target: 5760Updated: 2026-07-16